Quantitative evaluation of cryptococcal pathogenesis and antifungal drugs using a silkworm infection model with Cryptococcus neoformans
Authors:
Open Access
- 31 October 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Applied Microbiology
- Vol. 112 (1) , 138-146
Abstract
Aims: To develop an in vivo system that could quantitatively evaluate the therapeutic effects of antifungal drugs using a silkworm infection model with Cryptococcus neoformans. Methods and Results: Silkworms reared at 37°C died after an injection of viable serotype A C. neoformans fungus into the haemolymph. The serotype A C. neoformans, which is known to have higher mammal pathogenicity than the serotype D, was also more virulent against the silkworm. Furthermore, the deletion mutants of genes gpa1, pka1 and cna1, which are genes known to be necessary for the pathogenesis in mammals, showed an increase in the number of fungal cells necessary to kill half of the silkworm population (LD50 value). Antifungal drugs, amphotericin B, flucytosine, fluconazole and ketoconazole, showed therapeutic effects in silkworms infected with C. neoformans. However, amphotericin B was not therapeutically effective when injected into the silkworm intestine, comparable to the fact that amphotericin B is not absorbed by the intestine in mammals. Conclusions: The silkworm–C. neoformans infection model is useful for evaluating the therapeutic effects of antifungal drugs. Significance and Impact of the Study: The silkworm infection model has various advantages for screening antifungal drug candidates. We can also elucidate the cryptococcal pathogenesis and evaluate the in vivo pharmacokinetics and toxicity of each drug.Keywords
This publication has 41 references indexed in Scilit:
- Use of silkworms for identification of drug candidates having appropriate pharmacokinetics from plant sourcesBMC Pharmacology, 2010
- Silkworm as a model animal to evaluate drug candidate toxicity and metabolismComparative Biochemistry and Physiology Part C: Toxicology & Pharmacology, 2009
- Challenge of Drosophila melanogaster with Cryptococcus neoformans and Role of the Innate Immune ResponseEukaryotic Cell, 2004
- Quantitative Evaluation of the Therapeutic Effects of Antibiotics Using Silkworms Infected with Human Pathogenic MicroorganismsAntimicrobial Agents and Chemotherapy, 2004
- Cyclic AMP-Dependent Protein Kinase Catalytic Subunits Have Divergent Roles in Virulence Factor Production in Two Varieties of the Fungal Pathogen Cryptococcus neoformansEukaryotic Cell, 2004
- Cyclic AMP-Dependent Protein Kinase Controls Virulence of the Fungal Pathogen Cryptococcus neoformansMolecular and Cellular Biology, 2001
- Novel triazole antifungal agentsExpert Opinion on Investigational Drugs, 2000
- On the Origins of Congenic MATα and MATa Strains of the Pathogenic Yeast Cryptococcus neoformansFungal Genetics and Biology, 1999
- Antifungal Agents: Mode of Action, Mechanisms of Resistance, and Correlation of These Mechanisms with Bacterial ResistanceClinical Microbiology Reviews, 1999
- Cryptococcus neoformans mating and virulence are regulated by the G-protein α subunit GPA1 and cAMPGenes & Development, 1997